Coronavirus Disease 2019 Covid19 A Clinical Guide 1st Edition by Ali Gholamrezanezhad, Michael Dube ISBN 9781119789680 1119789680

Coronavirus Disease 2019 Covid19 A Clinical Guide 1st Edition by Ali Gholamrezanezhad, Michael Dube – Ebook PDF Instant Download/Delivery: 9781119789680 ,1119789680
Full download Coronavirus Disease 2019 Covid19 A Clinical Guide 1st Edition after payment

Product details:

ISBN 10: 1119789680
ISBN 13: 9781119789680
Author: Ali Gholamrezanezhad, Michael Dube

Provides comprehensive coverage of all key aspects of COVID-19, including: etiology, diagnosis, symptomatology, management, and treatment

Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides healthcare professionals at all levels with up-to-date knowledge about the clinical, epidemiological, genomic, virological, and radiologic features of COVID-19. Consolidating multiple systematic reviews and meta-analyses into a single volume, this comprehensive textbook also addresses health policies, mass casualty planning, healthcare worker safety, economic impact, lessons for future outbreaks, and other para-clinical and social aspects of the COVID-19 pandemic.

The text presents a thorough summary and critical analysis of COVID-19 based on an exhaustive review of recently published literature and data. Topics include the virologic characteristics of SARS-CoV-2, pulmonary and extrapulmonary manifestations and consequences of COVID-19, prevention and transmission control, the pandemic’s indirect impact to the care and management of other diseases, passive immunotherapy and its implications, diagnostic and treatment approaches for critically ill patients, and more. Edited by leading ¡practitioners at the forefront of COVID-19 research, this invaluable resource:

• Integrates clinical, radiological, and epidemiological data and discussion of prevention, diagnosis, and treatment
• Reviews the epidemiology, mechanisms of action, manifestations, and management of cardiovascular, neurological, and pulmonary diseases associated with COVID-19
• Covers diagnostic technologies, includes radiologic imaging, and RT-PCR testing
• Explores therapeutic approaches for managing a variety of complications
• Discusses post-vaccination symptom management and implications of immunization
• Addresses COVID-19 in pediatrics, in cancer patients, and in patients with lung disease, diabetes, ¡hypertension, obesity, and other underlying conditions

Coronavirus Disease 2019 (COVID-19): A Clinical Guide is an indispensable source of information for all clinicians, researchers, epidemiologists, nurses, radiologists, and healthcare managers working to address any aspect of the COVID-19 pandemic.

Coronavirus Disease 2019 Covid19 A Clinical Guide 1st Edition Table of contents:

1 COVID‐19: Epidemiology

Origin

Animal Host

Infectivity and Incubation

Modes of Transmission

Asymptomatic Transmission

Virulence and Mortality

Demographics

Disease Prevention

Global Impacts

Conclusions

References

2 COVID‐19: Virology

Coronaviruses

SARS‐CoV‐2

References

3 COVID‐19: Laboratory/Serologic Diagnostics

Molecular Diagnostics for COVID‐19

RT‐LAMP

CRISPR‐Based Techniques

Sequencing Techniques

Antigen Testing

Viral Culture

Antibody Testing for COVID‐19

Principles of Antibody Testing

Antibody Assays for SARS‐CoV‐2

Humoral Response to SARS‐CoV‐2 Infection

Current and Potential Applications of Antibody‐Based Tests in SARS‐CoV‐2

Conclusions and Future Directions

References

4 COVID‐19: Radiologic Diagnosis

Current Guidelines on When to Image

Technical Considerations to Limit Spread While Imaging

Imaging by Modality

Guidelines for Reporting

References

5 COVID‐19: Pathology Perspective

Gross and Histopathologic Findings in the Respiratory System

Gross and Histopathologic Findings in the Cardiovascular System

Histopathologic Findings in Kidney

Histopathologic Findings in the Gastrointestinal Tract and Liver

Histopathologic Findings in Brain

Histopathologic Findings in Skin

References

6 COVID‐19: Immunology

Anatomic Progression of COVID‐19

Adaptive Immune Response in the Nasal Passages and the Lungs

Immune Response to Immunization

Immune Correlates of Protection from Infection

Decline in Vaccine‐Induced Immune Responses over Time

Immune Consequences of Virologic Dissemination

Autoantibodies Against Type I IFN

Viral Evasion

Immune Dysregulation

Antibody‐Dependent Cellular Cytotoxicity

Cytokine Storm

Conclusions

Acknowledgments

References

7 COVID‐19: Presentation and Symptomatology

Pulmonary Manifestations of COVID‐19

Otolaryngologic Manifestations of COVID‐19

Gastrointestinal Manifestation of COVID‐19

Coronavirus and Pregnancy

Urologic Manifestations of COVID‐19

References

8 COVID‐19: Risk Stratification

Potential Biomarkers for COVID‐19 Detection, Severity, and Mortality

Host Risk Factors for COVID‐19

ABO Blood Type as an Additional Risk Factor

ML Methods for X‐Ray and CT Image Classification and Prediction

References

9 COVID‐19: Outpatient Management in Adults

Potential Conflicts of Interest

Initial Diagnosis

Prognosis and Choice of Admission Versus Outpatient Management

Home Monitoring

General Management Issues

Antivirals and Anti‐inflammatory Treatments

Anti‐SARS‐CoV‐2 mAbs

Oral Antivirals

Outpatient Anti‐inflammatory Interventions

Drugs That Are Not Recommended for Outpatient Use

Summary

References

10 COVID‐19: Inpatient Management

Respiratory Support for Hospitalized Patients with COVID‐19

Caring for the Critically Ill Patient with COVID‐19

Pharmacologic Therapies for Hospitalized Patients with COVID‐19

Extrapulmonary Disease in Acutely Ill Patients with COVID‐19

Performing Aerosol‐Generating Procedures in Patients with COVID‐19

Coordinating Patient Placement and Care in COVID‐19 Units

References

11 COVID‐19: ICU and Critical Care Management

Epidemiology of Critically Ill Patients with COVID‐19 Pneumonia

Infection Prevention and Control of COVID‐19 in the ICU

Cardiopulmonary Resuscitation in COVID‐19

Hemodynamic Support in COVID‐19

Management of Respiratory Failure from COVID‐19

Treatment of COVID‐19‐Associated ARDS with Corticosteroids

Tocilizumab for Critical COVID‐19 Illness

Extracorporeal Membrane Oxygenation for COVID‐19 ARDS

Tracheostomy Placement in COVID‐19

Standard ICU Care During COVID‐19

Venous Thromboembolism and Anticoagulation in COVID‐19

After the ICU: Challenges for Survivors of COVID‐19 Critical Illness

References

12 COVID‐19 in Pediatrics

Epidemiology

Clinical Manifestations

Approach to Diagnosis

Management

References

13 Pharmacologic Therapeutics for COVID‐19

Virus Life Cycle

Drug Development for SARS‐CoV‐2

Immune Responses that Contribute to COVID‐19 Pathology

Challenges to Discover and Deploy Drugs for a New Infectious Agent

Therapeutic Classes

Angiotensin Receptor Blockers

Viral Replication Inhibitors

Viral Protein Process Inhibitors

Recombinant Cytokine Therapy

Anticytokine Therapy

Neutralizing Antibody Therapy

Other Anti‐inflammatory Therapies

Experimental Therapeutics

References

14 Co‐infections and Secondary Infections in COVID‐19 Pneumonia

Bacterial Co‐infections

Fungal Superinfection

Parasitic

Viral

Summary

References

Note

15 COVID-19: Neurology Perspective

Epidemiology and Transmission Mode

Route to the Nervous System

Mechanisms for CNS Complications

Neurologic Manifestations

Therapeutic Strategies

Conclusion

References

16 COVID‐19: Cardiology Perspective

Epidemiology

Potential Mechanisms of Cardiovascular System Involvement in COVID‐19

Myocardial Injury in Acute COVID‐19

Kawasaki Disease, Multisystem Inflammatory Syndrome in Children, Pediatric Multisystem Syndrome, Multisystem Inflammatory Syndrome in Adults, and Acute COVID‐19 Cardiovascular Syndrome: Overlapping Post‐COVID‐19 Inflammatory Cardiac Syndromes

Arrhythmias in Acute COVID‐19

Postural Orthostatic Tachycardia Syndrome

Postacute Sequelae of SARS‐COV‐2 Infection

Long‐Term Management of COVID‐19 Cardiovascular Disease

Cardiovascular Effects of COVID‐19 Treatments

COVID‐19 in Special Populations

Conclusion

References

17 COVID‐19: Oncologic and Hematologic Considerations

The Natural History of COVID‐19 in Patients with Cancer

Diagnosing COVID‐19 in Patients with Cancer: Clinical, Serologic, and Imaging Considerations

COVID‐19 Therapeutics in Patients with Cancer

Practical Considerations in the Management of Patients with Cancer

Cancer Screening and Diagnosis

Cancer Therapy: Cytotoxic Chemotherapy

Cancer Therapy: Immunotherapy, Targeted Agents, and Biologics

Cancer Therapy: Radiation Therapy

Cancer Therapy: Cellular Therapy and Hematopoietic Transplantation

Oncologic Surgery

Thromboembolism in Patients with Cancer and COVID‐19

Clinical Trials

COVID‐19 and Other Vaccinations

Supportive Care

Use and Impact of Telemedicine on Caring for Patients with Cancer

Survivorship and Surveillance After Cancer Therapy

Palliative Care and Advance Care Planning

After COVID‐19: The Natural History of Cancer in the Postpandemic Era

References

18 COVID‐19: Dermatology Perspective

Cutaneous Manifestations of COVID‐19

Cutaneous Adverse Effects Caused by Use of Personal PMs against SARS‐CoV‐2

Challenges Posed by the COVID‐19 Pandemic for Dermatology: Impact on Dermatological Diseases, Dermatology Services, and Dermatology Practice

Dermatology Registries in Response to COVID‐19

Conclusion

References

19 COVID‐19: Ophthalmology Perspective

Conjunctiva and Sclera

Anterior Segment

Neuro‐ophthalmic Complications

Optic Nerve

Retina

Orbit

Conclusions

References

20 COVID‐19: Nutrition Perspectives

Safety Considerations for Nutrition Processes and Practice When Caring for Patients with COVID‐19

Nutrition in the Noncritically Ill Hospitalized Patient with COVID‐19

Nutrition in the Critically Ill Patient with COVID‐19

Post‐ICU Acute Care Management, Including Dysphagia and Multidisciplinary Care

Organization and System Considerations for Nutrition Management

Follow‐up for COVID‐19‐Related Nutrition Issues After Hospital Discharge

Conclusion

References

21 COVID‐19: Nursing Perspective

Care of the Patient in the Inpatient Setting

Advance Care Planning

Interdisciplinary Care

Discharge Planning: Transition to Outpatient/Specialty Care

Home Services and Transition to Home

Humanization of Care

Building Resilience

Conclusion

References

22 COVID‐19 Vaccination

Terminologies

Authorized Candidate Vaccines

Symptom Management

Prioritization and Acceptance

Passive Immunotherapy

Conclusion

Acknowledgments

References

23 Post‐COVID‐19 Vaccine Imaging Findings

Vaccines and Imaging: Past Experience

COVID‐19 Vaccine: Types and Mechanisms

Expected Findings Post‐COVID‐19 Vaccination

Vaccine‐Related Imaging Misinterpretation

Special Considerations for Oncologic Imaging with COVID‐19 Vaccination

Other COVID‐19 Vaccine–Induced Side Effects

Summary of Recommendations and Conclusion

References

Note

24 COVID‐19: Long-Term Pulmonary Consequences

Long‐Term Pulmonary Complications from Past Viral Pandemics

Monitoring for Long‐Term Pulmonary Consequences of COVID‐19 Infection

Long‐Term Clinical Sequelae of COVID‐19

Clinical Management

Summary Points

References

25 Psychological Effects and Neuropsychiatric Sequelae in COVID‐19 Patients

Depression and Anxiety

Posttraumatic Stress Disorder

Sleep Dysfunction

Neuropsychiatric Sequelae

Conclusions

References

26 Mental Health Effects of the COVID‐19 Pandemic on Healthcare Professionals

Overview of Psychological Impact on Healthcare Professionals

Impact on Healthcare Workers by Country

COVID‐19 Impact by Occupation and Healthcare Setting

Identifying Risk/Predisposing Factors

Mental Health Interventions and Strategies for HCWs

Conclusion

References

27 COVID‐19: Ethical Considerations in Clinical Practice

Crisis Standard of Care

Resource Allocation and the Pandemic

The Duty of Healthcare Providers

The Problem of Pseudoscience

Off‐Label Use of Medications

Contact Tracing

Conclusions

References

28 Racial, Ethnic, and Other Disparities in the Epidemiology and Care of COVID‐19

Disparities in Risk for Exposure in the United States

International Risk for Exposure to COVID‐19

Diagnostic Disparities

Clinical Disparities

Disparities in Patient Outcome

Disparities in Vaccination

Conclusion

References

29 Global Impact of COVID‐19 on Healthcare Systems

Healthcare Systems Before COVID‐19

International Trends and Collaboration

Africa

Asia Pacific

Europe

Middle East and North Africa

Americas

References

Note

30 COVID‐19: Mass Casualty Planning

Viral Pandemic

The Surge

Prehospital Planning

Hospital Planning

Outpatient Planning

Recovery Phase

References

Index

People also search for Coronavirus Disease 2019 Covid19 A Clinical Guide 1st Edition:

covid 19 stands for coronavirus disease 2019
    
effectiveness of the coronavirus disease 2019 bivalent vaccine
    
the coronavirus disease 2019 covid 19 pandemic
    
a review of coronavirus disease 2019 covid 19
    
coronavirus disease 2019 (covid-19)

Tags: Ali Gholamrezanezhad, Michael Dube, Coronavirus Disease 2019, Covid19